Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. - Wikidata - wikimedia - TriplyDB

Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.

Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.

http://www.wikidata.org/entity/Q37865363

about

Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications Wharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease PI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization The interaction between mesenchymal stem cells and steroids during inflammation.An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy.Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone.New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation.Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion Improved Protective Effect of Umbilical Cord Stem Cell Transplantation on Cisplatin-Induced Kidney Injury in Mice Pretreated with Antithymocyte Globulin Side-by-side comparison of the biological characteristics of human umbilical cord and adipose tissue-derived mesenchymal stem cells.Concise review: mesenchymal stem cells and translational medicine: emerging issues.Mesenchymal stem cells: a new trend for cell therapy.In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies.Therapeutic applications of mesenchymal stroma cells in pediatric diseases: current aspects and future perspectives Umbilical cord as a mesenchymal stem cell source for treating joint pathologies.The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides.Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation.Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.Clinical applications of mesenchymal stem cells Mesenchymal stem cells in the treatment of pediatric diseases.Stromal cells-are they really useful for GVHD?Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells.Melatonin enhances survival and preserves functional integrity of stem cells: A review.A future in our past: the umbilical cord for orthopaedic tissue engineering.Interactions between mesenchymal stem cells and the immune system.Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency.Isolation of mesenchymal stromal/stem cells from small-volume umbilical cord blood units that do not qualify for the banking system.Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity.Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.Human Umbilical Cord-Derived Mesenchymal Stem Cells Utilize Activin-A to Suppress Interferon-γ Production by Natural Killer Cells.Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation.Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation.Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?Stem Cell Banking for Regenerative and Personalized Medicine.Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.E-cadherin-mediated contact of endothelial progenitor cells with mesenchymal stem cells through β-catenin signaling.

P2860

Q27026892-AE6F8F96-EC01-445F-BA4A-21848D701A2A Q28083027-372A48B1-8EE1-459C-945F-DE59C7097154 Q28831131-3972FBF7-6FDE-4189-B736-DBA517207709 Q33695051-DB6DBE51-E0B9-42E9-8B94-495310B872CC Q34387727-D26F468B-469D-4419-BAAD-C193B2F53881 Q34480369-DB649C04-99E4-4B27-9B3C-37A72E8AD300 Q34991991-A1F08D79-1A43-49E4-8705-1808A69DCE7B Q35653672-58748EC0-4DE6-4D80-99C3-8135E3951848 Q36262326-E0477568-FEAD-4436-8225-0FF98CC1807C Q36530432-A1579BD7-1274-471A-9902-6CF1E7611388 Q37044121-B298EB65-81EA-44C2-8F2C-5061D3628A16 Q37056276-F0B8A539-85D2-4410-A975-9C6E3CF78AF2 Q37729093-85D4A7D4-0EE6-4FD5-98FF-ECE2D204450C Q37947420-42E59366-A3B4-456D-8391-879E165A473D Q37950842-6C39E3F5-2330-4449-ABAF-9F179CD1E8DF Q37999799-CA5F43BC-B597-4B8F-B4D2-86B2E8B0FC38 Q38052233-BE55B06C-EE1A-49DA-9062-86D63A33BF31 Q38055145-559768F0-B81A-46ED-8EA6-A8370ADFB18F Q38110707-715EED8E-7550-40AF-8DFD-443BB8578239 Q38122364-142C81E0-CB45-4378-83B9-0349EC45E4A7 Q38127615-AD4931E6-C447-4374-8C9B-4E1446691214 Q38181957-785BA12A-CF73-4101-B453-BCDE297A749D Q38275024-2955D9DE-2098-4E87-A7F6-336CF4EC6FB1 Q38979530-B90C80AE-B05A-4CBE-8D34-225E1C35BC8B Q39052439-23C1E646-C5C5-4ABC-BFD0-2CA11670C9ED Q39142316-AC50A097-AF43-43E9-80AB-BE59F292B6E9 Q40092032-E3474895-A2C5-49A0-AE3F-44FDF2C5213E Q40785927-30E5998E-1CDC-4E86-AE32-36DE3959909C Q41789455-AEEACF74-7A28-4CD5-9D52-7130B4F95BFF Q42325850-D1EE5E34-D147-4BDF-AE41-480FB2301CFC Q43082916-D9D7DCC6-A393-45AD-8B97-5AF4631BF962 Q43942762-77DA352A-A9B2-408C-8022-641FD1526A30 Q47787016-80D9FD9A-8879-41EB-9E92-B85FC3D252F9 Q50224283-B1581E52-9B7B-4DBF-B4D7-8E522994E6FA Q51301197-DAD602A1-2F03-47D0-8D9F-693BBC977B6B Q52680964-9436F601-1A2D-495D-BB19-1B26D8B59F4B Q52917325-9C93D7BC-3844-4AA7-9DE7-03B31B2E63BF Q53211327-CF6D4D48-40B5-41A9-8594-12FE9A00D3A9

P2860

Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.

http://www.wikidata.org/entity/Q37865363

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effective treatment of severe ...... erived mesenchymal stem cells.

@en

Effective treatment of severe ...... erived mesenchymal stem cells.

@nl

type

label

Effective treatment of severe ...... erived mesenchymal stem cells.

@en

Effective treatment of severe ...... erived mesenchymal stem cells.

@nl

prefLabel

Effective treatment of severe ...... erived mesenchymal stem cells.

@en

Effective treatment of severe ...... erived mesenchymal stem cells.

@nl

P1433

Q37865363-7A08A786-60D8-4217-88E9-879A4FAD192D

P1476

Q37865363-406BCADF-9233-4A2F-A718-4AE5D9982D66

P2093

Q37865363-2A517309-FA60-4FFB-BD25-307FD788EA64

Q37865363-325CE5FF-15A5-43AB-AFFE-B1AF00403794

Q37865363-450E864E-5B09-416C-92AE-61C868E2AED6

Q37865363-616562B2-91FE-45A7-B7DC-838AB78C5E47

Q37865363-8C882F04-05F1-4D82-8DA1-5805C85D2099

Q37865363-AC3B15FF-9E5D-4AF0-83FD-62FFE1351459

Q37865363-C01922E4-6AEC-459E-9511-2626582024E6

Q37865363-ED69C999-63B2-48C8-9A23-DBB14D2EABC7

Q37865363-FE9FB958-D4AB-4047-BED2-9BFAB8FBA1BC

P304

Q37865363-4F0E0A3E-DC6E-4D90-BF71-44874556BF03

P31

Q37865363-4023D1AD-6C48-45C8-98DF-F6AA47C0F240

P356

Q37865363-8CF21A72-D83A-4437-89F4-F5E97A34EE83

P433

Q37865363-49B87306-B0C3-4DDD-A829-FAF969F8102C

P478

Q37865363-AC171734-F112-4193-8263-1FD2D1425999

P50

Q37865363-C279FA3D-B9B4-4767-AF0C-89855D8A32F1

P577

Q37865363-B64E934A-49E1-4EEB-8966-144843884BBA

P698

Q37865363-DDA21153-E269-48EC-8C5C-DD71E24CA857

P356

TP.0B013E31821ABA18

P1433

Transplantation

P1476

Effective treatment of severe ...... derived mesenchymal stem cells

@en

P2093

Chin-Kan Chan

http://www.w3.org/2001/XMLSchema#string

Ching-Tien Peng

http://www.w3.org/2001/XMLSchema#string

Chris Tsai

http://www.w3.org/2001/XMLSchema#string

Han-Ping Wu

http://www.w3.org/2001/XMLSchema#string

Kang-Hsi Wu

http://www.w3.org/2001/XMLSchema#string

Martin Sieber

http://www.w3.org/2001/XMLSchema#string

Ming Ho

http://www.w3.org/2001/XMLSchema#string

Tsan-Hung Chiu

http://www.w3.org/2001/XMLSchema#string

Yu-Hsiang Chang

http://www.w3.org/2001/XMLSchema#string

P304

1412-1416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0B013E31821ABA18

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Jing-Long Huang

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21494176

http://www.w3.org/2001/XMLSchema#string